Title : Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice.

Pub. Date : 2017 Dec

PMID : 28464271






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-kappaB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice. picroside II tumor necrosis factor (ligand) superfamily, member 11 Mus musculus
2 Results demonstrated picroside II strongly inhibited RANKL-induced osteoclast formation when added during the early stage of BMMs cultures, suggesting that it acts on osteoclast precursors to inhibit RANKL/RANK signaling. picroside II tumor necrosis factor (ligand) superfamily, member 11 Mus musculus
3 Results demonstrated picroside II strongly inhibited RANKL-induced osteoclast formation when added during the early stage of BMMs cultures, suggesting that it acts on osteoclast precursors to inhibit RANKL/RANK signaling. picroside II tumor necrosis factor (ligand) superfamily, member 11 Mus musculus